Filing Details
- Accession Number:
- 0001209191-16-127845
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-06-14 18:45:11
- Reporting Period:
- 2016-06-13
- Filing Date:
- 2016-06-14
- Accepted Time:
- 2016-06-14 18:45:11
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1305253 | Eiger Biopharmaceuticals Inc. | EIGR | Biological Products, (No Disgnostic Substances) (2836) | 361004130 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1488919 | P James Shaffer | 350 Cambridge Ave, Suite 350 Palo Alto CA 94306 | Chief Business Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2016-06-13 | 730 | $22.16 | 1,975 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2016-06-13 | 100 | $22.17 | 2,075 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2016-06-13 | 420 | $22.20 | 2,495 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct |